Zealand Pharma A/S (CPH:ZEAL)

Zealand Pharma Ratios and Metrics

Market cap in millions DKK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	22,088	32,852	50,548	21,785	10,366	6,271
Market Cap Growth	-27.79%	-35.01%	132.03%	110.16%	65.31%	-28.46%
Enterprise Value	8,034	17,089	41,733	20,319	10,519	5,364
Last Close Price	312.60	466.40	715.50	373.20	201.40	145.10
PE Ratio	3.50	5.09	-	-	-	-
PS Ratio	2.39	3.57	806.30	63.55	99.69	57.77
PB Ratio	1.53	2.22	5.87	13.68	12.71	6.76
P/TBV Ratio	1.53	2.22	5.88	13.78	12.71	7.17
P/FCF Ratio	3.49	5.06	-	-	-	-
P/OCF Ratio	3.47	5.03	-	-	-	-
EV/Sales Ratio	0.87	1.86	665.70	59.28	101.16	49.41
EV/EBITDA Ratio	1.18	2.47	-	-	-	-
EV/EBIT Ratio	1.18	2.47	-	-	-	-
EV/FCF Ratio	1.27	2.63	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.05	0.08	0.64	0.85
Debt / EBITDA Ratio	0.06	0.06	-	-	-	-
Debt / FCF Ratio	0.07	0.06	-	-	-	-
Net Debt / Equity Ratio	-0.97	-0.99	-1.00	-0.95	-0.80	-0.69
Net Debt / EBITDA Ratio	-2.07	-2.12	6.88	2.73	0.90	0.83
Net Debt / FCF Ratio	-2.22	-2.26	9.20	3.47	0.69	0.52
Asset Turnover	0.76	0.72	0.01	0.20	0.06	0.06
Inventory Turnover	-	-	0.85	0.69	-	0.12
Quick Ratio	36.40	23.20	20.85	6.23	6.73	4.80
Current Ratio	37.17	23.57	21.14	6.25	6.73	5.15
Return on Equity (ROE)	56.16%	55.06%	-21.13%	-58.43%	-110.75%	-69.99%
Return on Assets (ROA)	34.72%	33.97%	-13.81%	-19.93%	-28.30%	-25.53%
Return on Invested Capital (ROIC)	2303.69%	1401.57%	-294.62%	-465.46%	-363.56%	-402.18%
Return on Capital Employed (ROCE)	45.50%	45.30%	-13.90%	-33.10%	-60.70%	-45.10%
Earnings Yield	28.96%	19.65%	-2.13%	-3.23%	-11.60%	-16.24%
FCF Yield	28.63%	19.78%	-1.86%	-2.01%	-9.20%	-19.68%
Buyback Yield / Dilution	-4.13%	-7.70%	-17.40%	-22.49%	-7.77%	-11.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.